ORIUCHI Noboru

写真a

Title

Professor

Research Fields, Keywords

Targeted Radionuclide Therapy, Molecular imaging

Mail Address

E-mail address

Laboratory Phone number

+81-24-581-5165

Laboratory Fax number

+81-24-581-5165

Current Affiliation Organization 【 display / non-display

  • Duty ,  Fukushima Global Medical Science Center ,  Advanced Clinical Research Center ,  Professor

Graduate School 【 display / non-display

  • Gunma University ,  Graduate School, Division of Medical Sciences ,  Doctor's Course ,  Completed ,  JAPAN ,  1991.03

Academic Society Affiliations 【 display / non-display

  • SNM ,  UNITED STATES

Field of expertise (Grants-in-aid for Scientific Research classification) 【 display / non-display

  • Radiation science

Qualification acquired 【 display / non-display

  • Doctor

Current state of research and teaching activities 【 display / non-display

  • Medicine

 

Papers 【 display / non-display

  • Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy

    Noboru Oriuchi, Shigeyasu Sugawara, Tohru Shiga

    Biomedicines ,  8 (9) 371 - 371 ,  2020.09

    Multiple Authorship

    DOI

  • Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.

    Kaira K, Endo M, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Tsuya A, Nakamura Y, Naito T, Hayashi I, Serizawa M, Koh Y, Hanaoka H, Tominaga H, Oriuchi N, Kondo H, Nakajima T, Yamamoto N

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology ,  28 (23) 3746 - 53 ,  2010.08

    Multiple Authorship ,  ISBN: 0732-183X

    DOI PubMed

  • Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.

    Kaira K, Oriuchi N, Otani Y, Shimizu K, Tanaka S, Imai H, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Dobashi K, Kanai Y, Endou H, Nakajima T, Endo K, Mori M

    Clinical cancer research : an official journal of the American Association for Cancer Research ,  13 (21) 6369 - 78 ,  2007.11

    Multiple Authorship ,  ISBN: 1078-0432

    DOI PubMed

  • Different biodistribution of 99mTc-labeled chimeric mouse-human monoclonal antibody between athymic mice model and human

    Oriuchi N, Watanabe N, Sugiyama S, Higuchi T, Imai K, Yamanaka H, Hashimoto M, Kanda H, Endo K

    Br J Cancer ,  73:   1466 - 1472 ,  1996

    Multiple Authorship

  • 18F-FMT uptake seen within primary cancer on PET helps predict outcome of non-small cell lung cancer.

    Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Mori M, Endo K

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine ,  50 (11) 1770 - 6 ,  2009.11

    Multiple Authorship ,  ISBN: 0161-5505

    DOI PubMed

display all >>

Books 【 display / non-display

  • Frontier of Antibody Engineering for Next-generation Theranostics

    Izumi Kumagai (Part:Present status and future prospect of radiopharmaceuticals) (Page:171-175)

    CMC Books Co. ,  2019.09 ,  ISBN: 978-4-7813-1378-8

    Oriuchi Noboru ,  Tokyo

  • Perfect guide of urological examination

    Oya Mototsugu, Kondo Yukihiro, Kojima Yoshiyuki (Part:Radionuclide Renography) (Page:64-66)

    Igaku-shoin ,  2017.04

    Oriuchi Noboru ,  Tokyo

  • Perfect guide of urological examination

    Oya Mototsugu, Kondo Yukihiro, Kojima Yoshiyuki (Part:FDG-PET/CT) (Page:74-76)

    Igaku-shoin ,  2017.04

    Oriuchi Noboru ,  Tokyo

Joint Research activities 【 display / non-display

  • Analyses of chromosomal abnormality in normal somatic cells induced by alpha-particle therapy

    Collaboration in College  

    Project Year:2019.04 - 2022.03 

    Investigator(s): Oriuchi Noboru 

  • Innovative brain tumor diagnosis using C-11 methionine PET for Precision Medicine

    Assistance  

    Project Year:2017.04 - 2019.03 

    Investigator(s): Shiga Tohru  ,  Member: Oriuchi Noboru,

Presentations 【 display / non-display

  • Similarities of dosimetry between 123I-MIBG and 211At-MABG in PC12 model mice

    2021.11
     
     

  • Radiotoxicity for organ damage of free 211At in normal mice

    2021.11
     
     

  • Effects of repeated 211At-MABG therapy on tumor growth in a pheochromocytoma

    2021.11
     
     

  • Correlation of radiotoxicity and dosimetry of 211At-MABG in normal mice as companion diagnostic drug

    2021.11
     
     

  • Biodistribution of 211At-labeled anti-CD33 antibody in acute myeloid leukaemia mouse model

    2021.11
     
     

display all >>